ArticleAmerican journal of respiratory and critical care medicine2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
Open access · hybridAbstract read
In one paragraph
Article in American journal of respiratory and critical care medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 5 citations in OpenAlex.
- Article
- Thymic alveolar type 2 epithelial mimetic cells revealed by RUNX1 deficiency.Nature immunology · 2026Article
- Recent advances in pulmonary fibrosis: from lung surfactant to the immune connection.Respiratory research · 2026Review
- Single-cell transcriptomic insights into the immune heterogeneity of immune checkpoint inhibitors related organ toxicities.Frontiers in immunology · 2026Review
- Omics-based biomarkers of immune-related organ toxicities associated with immune checkpoint inhibitors: a scoping review and evidence map.Frontiers in immunology · 2026Article
- Harnessing multi-omics approaches to decipher tumor evolution and improve diagnosis and therapy in lung cancer.Biomarker research · 2025Review
- Does Autoimmune Response Against Surfactant Protein Cause Interstitial Lung Disease?American journal of respiratory and critical care medicine · 2024Article
Corrections and comments
- Commented on by
Authors and funding
44 authors at 20 institutions in 7 countries.
Nina WyssInstitute of Immunobiology.
Fiamma BernerInstitute of Immunobiology.
Vincent WalterDepartment of Dermatology, University Hospital Tübingen.
Ann-Kristin JochumInstitute of Immunobiology.
Mette T PurdeInstitute of Immunobiology.
Marie-Therese AbdouInstitute of Immunobiology.
Tobias SinnbergDepartment of Dermatology, University Hospital Tübingen.
Kathrin HofmeisterDepartment of Dermatology, University Hospital Tübingen.
Oltin T PopInstitute of Immunobiology.
Omar Hasan AliInstitute of Immunobiology.
Jens BaueriFIT Cluster of Excellence 2180 "Image-guided and Functionally Instructed Tumor Therapies,".
Hung-Wei ChengInstitute of Immunobiology.
Mechthild LütgeInstitute of Immunobiology.
Niklas KlümperInstitute for Experimental Oncology.
Stefan DiemDepartment of Oncology and Hematology.
Zeynep Kosaloglu-YalcinCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California.
Yizheng ZhangDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
Laura SellmerDepartment of Medicine V, University Hospital, and.
Boris MacekQuantitative Proteomics, Interfaculty Institute of Cell Biology, Faculty of Science.
Julia KarbachDepartment of Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany.
David KönigMedical Oncology, University Hospital Basel, Basel, Switzerland.
Heinz LäubliMedical Oncology, University Hospital Basel, Basel, Switzerland.
Lars ZenderiFIT Cluster of Excellence 2180 "Image-guided and Functionally Instructed Tumor Therapies,".
Britta S MeyerResearch Unit Evolutionary Immunogenomics, Department of Biology, University of Hamburg, Hamburg, Germany.
Christoph DriessenDepartment of Oncology and Hematology.
Christian M SchürchDepartment of Pathology and Neuropathology, University Hospital and Comprehensive Cancer Center Tübingen, Tübingen, Germany.
Wolfram JochumInstitute of Pathology.
Teresa AmaralSkin Cancer Center, Department of Dermatology, and.
Lucie HeinzerlingDepartment of Dermatology, Ludwig Maximilian University of Munich, Munich, Germany.
Antonio CozzioDepartment of Dermatology, and.
Ahmed N HegazyDepartment of Gastroenterology, Infectious Diseases and Rheumatology, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt- Universität zu Berlin, Berlin, Germany.
Tino SchneiderDepartment of Pneumology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Martin H BrutscheDepartment of Pneumology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
Alessandro SetteCenter for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California.
Tobias L LenzResearch Unit Evolutionary Immunogenomics, Department of Biology, University of Hamburg, Hamburg, Germany.
Juliane WalziFIT Cluster of Excellence 2180 "Image-guided and Functionally Instructed Tumor Therapies,".
Hans-Georg RammenseeiFIT Cluster of Excellence 2180 "Image-guided and Functionally Instructed Tumor Therapies,".
Martin FrühDepartment of Oncology and Hematology.
Elke JägerDepartment of Oncology and Hematology, Krankenhaus Nordwest, Frankfurt, Germany.
Burkhard BecherInstitute of Experimental Immunology, University of Zurich, Zurich, Switzerland; and.
Amanda TufmanDepartment of Medicine V, University Hospital, and.
Nicolas NuñezFacultad de Ciencias Químicas, Departamento de Bioquímica Clínica, Universidad Nacional de Córdoba y Centro de Investigaciones en Bioquímica Clínica e Inmunología, Córdoba, Argentina.
Markus JoergerDepartment of Oncology and Hematology.
Lukas FlatzInstitute of Immunobiology.ORCID 0000-0001-9683-8390
Institute of Immunology · HRGerman Cancer Research Center · DEPalmetto Hematology Oncology · USGerman Center for Lung Research · DEKantonsspital St. Gallen · CHKrankenhaus Nordwest · DELa Jolla Institute for Immunology · USUniversität Hamburg · DEUniversity Children's Hospital Tübingen · DEUniversity of Basel · CHUniversity of Zurich · CHGuided Therapeutics (United States) · USLeibniz Association · DELudwig-Maximilians-Universität München · DEQuantitative BioSciences · USSkin Cancer Foundation · USTaipei Institute of Pathology · TWUniversidad Nacional de Córdoba · ARUniversity Hospital Bonn · DEUniversity of Bern · CH
Funding
Deutsche ForschungsgemeinschaftDeutsche KrebshilfeForschungsförderung Kantonsspital St. GallenGerman Cancer Consortium (DKTK)Lungenliga SchweizWilhelm Sander Stiftung
Abstract
PubMed holds no abstract for this paper.
Indexed as
AutoantibodiesImmune Checkpoint InhibitorsLung NeoplasmsPneumoniaAgedAutoimmunityCarcinoma, Non-Small-Cell LungCohort StudiesFemaleHumansMaleMiddle AgedPulmonary Surfactant-Associated Protein BAutoantibodiesImmune Checkpoint InhibitorsPulmonary Surfactant-Associated Protein Bautoimmunityimmune checkpoint inhibitornon–small-cell lung cancerpneumonitissurfactant protein B
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.